换一批
换一批Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial
作者：
Li, Jin [1]
;
Guo, Weijian [2]
;
Bai, Yuxian [3]
;
Deng, Yanhong [4]
;
Yang, Lei [5]
;
Chen, Zhendong [6]
;
Zhong, Haijun [7]
;
Xu, Ruihua [8]
;
Pan, Hongming [9]
;
Shu, Yongqian [10]
;
Yuan, Ying [11]
;
Zhou, Jianfeng [12]
;
Xu, Nong [13]
;
Liu, Tianshu [14]
;
Ma, Dong [15]
;
Wu, Changping [16]
;
Cheng, Ying [17]
;
Xu, Jianming [18]
;
Chen, Donghui [19]
;
Li, Wei [20]
;
Sun, Sanyuan [21]
;
Yu, Zhuang [22]
;
Cao, Peiguo [23]
;
Shen, Lin [24]
;
Chen, Haihui [25]
;
Wang, Shubin [26]
;
Wang, Hongbing [27]
;
Fan, Songhua [28]
;
Guo, Xiaojun [29]
;
Wang, Ning [30]
;
Han, Rubing ;
Zhang, Bin ;
Qin, Shukui
作者单位：
Anhui Med Univ, Hosp 2, Dept Med Oncol, Hefei, Peoples R China
[1]
Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China
[2]
Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China
[3]
Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou, Peoples R China
[4]
Sun Yat Sen Univ, Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China
[5]
Tongji Univ, East Hosp, Dept Med Oncol, Shanghai, Peoples R China
[6]
Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Med Oncol, Shanghai, Peoples R China
[7]
Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Peoples R China
[8]
Nantong Canc Hosp, Dept Med Oncol, Nantong, Peoples R China
[9]
Jiangsu Prov Hosp, Dept Med Oncol, Nanjing, Peoples R China
[10]
Zhejiang Univ, Affiliated Hosp 2, Dept Med Oncol, Hangzhou, Peoples R China
[11]
Peking Union Med Coll Hosp, Dept Oncol, Beijing, Peoples R China
[12]
Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Med Oncol, Hangzhou, Peoples R China
[13]
Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China
[14]
Guangdong Prov Peoples Hosp, Dept Med Oncol, Guangzhou, Peoples R China
[15]
First Peoples Hosp Changzhou, Dept Med Oncol, Changzhou, Jiangsu, Peoples R China
[16]
Jilin Prov Canc Hosp, Dept Med Oncol, Changchun, Peoples R China
[17]
Peoples Liberat Army Gen Hosp, Med Ctr Chinese 5, Dept Med Oncol, Beijing, Peoples R China
[18]
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 1, Dept Med Oncol, Shanghai, Peoples R China
[19]
First Hosp Jilin Univ, Dept Med Oncol, Changchun, Peoples R China
[20]
Xuzhou Cent Hosp, Dept Med Oncol, Xuzhou, Jiangsu, Peoples R China
[21]
Qingdao Univ, Med Coll, Affiliated Hosp, Dept Med Oncol, Qingdao, Peoples R China
[22]
Cent South Univ, Xiangya Hosp 3, Xiangya Hosp, Dept Med Oncol, Changsha, Peoples R China
[23]
Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis &
[24]
Liuzhou Workers Hosp, Dept Med Oncol, Liuzhou, Peoples R China
[25]
Beijing Univ, ShenZhen Hosp, Dept Med Oncol, Shenzhen, Peoples R China
[26]
Xuzhou Med Coll, Affiliated Hosp, Dept Med Oncol, Xuzhou, Jiangsu, Peoples R China
[27]
Hutchison MediPharma Ltd, Shanghai, Peoples R China
[28]
Lilly China, Drug Dev & Med Affairs Ctr, Shanghai, Peoples R China
[29]
Jinling Hosp, Canc Ctr, Nanjing, Peoples R China
[30]
发布时间
2022-10-11
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
